Aurobindo PharmaAUROPHARMA 
$18.63-0.07%24h
-0.07%24h
Global rank1478
Market cap$10.92B
Change 7d2.23%
YTD Performance44.06%
SP500 benchmarkOutperform
P/E0.57
P/S3.72
Revenue$2.93B
Earnings$229.78M
Dividend yield-
Main Sector
Healthcare
Aurobindo Pharma (AUROPHARMA) Cash on Hand
AUROPHARMA Cash on Hand in 2022: $741.88M
According to Aurobindo Pharma latest financial reports the cash on hand of AUROPHARMA is $741.88M, an increase of 36.55% to 2022. At the end of 2022 company had $543.28M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
AUROPHARMA Cash on Hand History from 2019 to 2023
-
Value:-
AUROPHARMA Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $741.88M | 36.55% |
| 2022 | $543.28M | -18.92% |
| 2021 | $670.06M | 98.34% |
| 2020 | $337.84M | 46.93% |
| 2019 | $229.93M | - |
View the Top Cash on Hand Companies 
